Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders

CE Muller, S Ferré - Recent Patents on CNS Drug Discovery …, 2007 - ingentaconnect.com
Adenosine A2A receptors are highly concentrated in the striatum, where they play an
important modulatory role of glutamatergic transmission to the GABAergic enkephalinergic …
被引用次数：104 相关文章

Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders.

CE Müller, S Ferré - Recent Patents on CNS Drug Discovery, 2007 - europepmc.org
Adenosine A (2A) receptors are highly concentrated in the striatum, where they play an
important modulatory role of glutamatergic transmission to the GABAergic enkephalinergic …
[PDF] psu.edu

[PDF][PDF] Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders

CE Müller, S Ferré - Recent Patents on CNS Drug Discovery, 2007 - Citeseer
Adenosine A2A receptors are highly concentrated in the striatum, where they play an
important modulatory role of glutamatergic transmission to the GABAergic enkephalinergic …

Blocking striatal adenosine A2A receptors: a new strategy for basal ganglia disorders

CE Müller, S Ferré - Recent patents on CNS drug …, 2007 - pubmed.ncbi.nlm.nih.gov
Adenosine A (2A) receptors are highly concentrated in the striatum, where they play an
important modulatory role of glutamatergic transmission to the GABAergic enkephalinergic …